$9.17
0.161.78%
At close: Aug 14, 5:00 PM EST
$9.08
-0.09-0.98%
After Hours: Aug 13, 7:39 AM EST
Xilio Therapeutics Inc
XLONASDAQ
Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open
Xilio Therapeutics Market Sentiment
Market sentiment signals for Xilio Therapeutics (XLO): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus— Outperform
Short Interest▼ 7.2% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Outperform
2 analysts
Options Flow (P/C)
—
Avg Consensus PT
$3
-67.0%
Highest Price Target
$4
-55.9%
Raymond James
Lowest Price Target
$2
-78.0%
Leerink Partners
Short Interest
7.2%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 6, 2025 | Leerink Partners | Daina Graybosch— | -78.0% | $2 | Initiate | Outperform |
| Nov 8, 2024 | Raymond James | Dane Leone— | -55.9% | $6 → $4 | Maintained | Outperform |
